Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
1 Online-Ressource.
Language
Englisch

Bibliographic citation
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia ; volume:35 ; number:9 ; day:8 ; month:7 ; year:2021 ; pages:2735 ; date:9.2021
Leukemia ; 35, Heft 9 (8.7.2021), 2735, 9.2021

Creator
Werf, Inge van der
Wojtuszkiewicz, Anna
Yao, Huilan
Sciarrillo, Rocco
Meggendorfer, Manja
Hutter, Stephan
Walter, Wencke
Janssen, Jeroen
Kern, Wolfgang
Haferlach, Claudia
Haferlach, Torsten
Jansen, Gerrit
Kaspers, Gertjan J. L.
Groen, Richard
Ossenkoppele, Gert
Cloos, Jacqueline
Contributor
SpringerLink (Online service)

DOI
10.1038/s41375-021-01340-z
URN
urn:nbn:de:101:1-2411022106046.473901620594
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Werf, Inge van der
  • Wojtuszkiewicz, Anna
  • Yao, Huilan
  • Sciarrillo, Rocco
  • Meggendorfer, Manja
  • Hutter, Stephan
  • Walter, Wencke
  • Janssen, Jeroen
  • Kern, Wolfgang
  • Haferlach, Claudia
  • Haferlach, Torsten
  • Jansen, Gerrit
  • Kaspers, Gertjan J. L.
  • Groen, Richard
  • Ossenkoppele, Gert
  • Cloos, Jacqueline
  • SpringerLink (Online service)

Other Objects (12)

RSK1 dependency in FLT3-ITD acute myeloid leukemia

RSK1 dependency in FLT3-ITD acute myeloid leukemia

ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia

ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia

Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia

Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia

The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia

Hochschulschrift

The role of GAB2 in FLT3-ITD mutant acute myeloid leukemia

Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo

Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo

A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia

A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia

Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation

Autophagy activation mediates resistance to FLT3 inhibitors in acute myeloid leukemia with FLT3-ITD mutation

The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia

Hochschulschrift

The cooperative effect of IL3RB and FLT3-ITD in acute myeloid leukemia

miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia

miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia

GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia

GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia

Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors

Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors

Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation

Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation

Related objects